TLRgeting Evasion of Immune Pathways in Glioblastoma
- PMID: 28388423
- DOI: 10.1016/j.stem.2017.03.018
TLRgeting Evasion of Immune Pathways in Glioblastoma
Abstract
Glioblastoma (GBM) is an intractable brain cancer that presents a strongly immunosuppressive microenvironment. Alvarado et al. (2016) now report that GBM cancer stem cells (CSCs) downregulate Toll-like receptor (TLR) 4 to evade immune suppression, and that activating downstream TLR signaling pathways can reduce tumor growth and disrupt CSC self-renewal.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment on
-
Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression.Cell Stem Cell. 2017 Apr 6;20(4):450-461.e4. doi: 10.1016/j.stem.2016.12.001. Epub 2017 Jan 12. Cell Stem Cell. 2017. PMID: 28089910 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
